Medicare now covers GLP-1s for weight loss: Here’s how to use the new Bridge program
Headline from Wyoming Tribune Eagle, on the newest of 2 developments
GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications for a $50 copay, starting July 1, 2026.
Wyoming Tribune Eagle's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Developments in this update
2 dated developments, oldest first, newest marked. Each is named by one outlet's own headline; open its reports to see every outlet that covered it.
GLP-1 drugs available for $50 a month under Medicare pilot
Headline from News Nation Now ·
Newest
Medicare now covers GLP-1s for weight loss: Here’s how to use the new Bridge program
A new Medicare program offers some beneficiaries GLP-1 drugs at just $50 a month for weight loss, but the program is temporary, and eligibility rules could shut out many patients.
Patent protection for Wegovy — Novo Nordisk’s blockbuster weight loss drug, which contains the second generation GLP-1 active ingredient and is at least twice as effective — is expected to expire by the decade’s end.
NEW YORK (AP) — Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new t…
Some adults aged 65 and above will be able to get the drug for $50 through Medicare GLP-1, a temporary program Kathryn, a retiree who worked in healthcare, has throughout her life experienced “cyclical weight-loss, weight-gain”.
Popular — and expensive — GLP-1 weight loss drugs just got a lot cheaper for many older Americans. Starting Wednesday, the federal government is offering a selection of the brand name medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medi…
NEW YORK -- The federal government is now offering a selection of brand-name weight loss medications to certain Medicare and Medicare Advantage beneficiaries for $50 a month through a new trial called Medicare GLP-1 Bridge.
The federal government has launched a trial program, Medicare GLP-1 Bridge, to provide certain Medicare and Medicare Advantage beneficiaries with a selection of brand-name weight loss drugs for $50 a month, in an effort to reduce the cost barrier to access.
The latest breakthrough for GLP-1 drugs isn’t scientific. It’s financial. As of July 1, Medicare is providing coverage of GLP-1 medications for weight loss for just a $50 co-pay, potentially enabling millions more Americans to get onto this much-hyped new class of drugs.
GoodRx reports that Medicare's new GLP-1 Bridge program allows eligible Part D enrollees to access weight-loss medications for a $50 copay, starting July 1, 2026.
